A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype.

Chris Balak, Newell Belnap, Keri Ramsey, Shelagh Joss, Koen Devriendt, Marcus Naymik, Wayne Jepsen, Ashley L Siniard, Szabolcs Szelinger, Mary E Parker, Ryan Richholt, Tyler Izatt, Madison LaFleur, Panieh Terraf, Lorida Llaci, Matt De Both, Ignazio S Piras, Sampathkumar Rangasamy, Isabelle Schrauwen, David W Craig, Matt Huentelman, Vinodh Narayanan
Author Information
  1. Chris Balak: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona. ORCID
  2. Newell Belnap: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  3. Keri Ramsey: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  4. Shelagh Joss: West of Scotland Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
  5. Koen Devriendt: Center for Human Genetics (Centrum Menselijke Erfelijkheid), University of Leuven, Leuven, Belgium.
  6. Marcus Naymik: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  7. Wayne Jepsen: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  8. Ashley L Siniard: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  9. Szabolcs Szelinger: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  10. Mary E Parker: Department of Physical Therapy, Texas State University, San Marcos, Texas.
  11. Ryan Richholt: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  12. Tyler Izatt: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  13. Madison LaFleur: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  14. Panieh Terraf: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  15. Lorida Llaci: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  16. Matt De Both: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  17. Ignazio S Piras: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  18. Sampathkumar Rangasamy: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  19. Isabelle Schrauwen: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona. ORCID
  20. David W Craig: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  21. Matt Huentelman: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.
  22. Vinodh Narayanan: Neurogenomics Division, Center for Rare Childhood Disorders (C4RCD), Translational Genomics Research Institute, Phoenix, Arizona.

Abstract

Chromosome 1q41-q42 deletions have recently been associated with a recognizable neurodevelopmental syndrome of early childhood (OMIM 612530). Within this group, a predominant phenotype of developmental delay (DD), intellectual disability (ID), epilepsy, distinct dysmorphology, and brain anomalies on magnetic resonance imaging/computed tomography has emerged. Previous reports of patients with de novo deletions at 1q41-q42 have led to the identification of an evolving smallest region of overlap which has included several potentially causal genes including DISP1, TP53BP2, and FBXO28. In a recent report, a cohort of patients with de novo mutations in WDR26 was described that shared many of the clinical features originally described in the 1q41-q42 microdeletion syndrome (MDS). Here, we describe a novel germline FBXO28 frameshift mutation in a 3-year-old girl with intractable epilepsy, ID, DD, and other features which overlap those of the 1q41-q42 MDS. Through a familial whole-exome sequencing study, we identified a de novo FBXO28 c.972_973delACinsG (p.Arg325GlufsX3) frameshift mutation in the proband. The frameshift and resulting premature nonsense mutation have not been reported in any genomic database. This child does not have a large 1q41-q42 deletion, nor does she harbor a WDR26 mutation. Our case joins a previously reported patient also in whom FBXO28 was affected but WDR26 was not. These findings support the idea that FBXO28 is a monogenic disease gene and contributes to the complex neurodevelopmental phenotype of the 1q41-q42 gene deletion syndrome.

Keywords

MeSH Term

Body Dysmorphic Disorders
Child, Preschool
Chromosome Deletion
Chromosomes, Human, Pair 1
Developmental Disabilities
Drug Resistant Epilepsy
Exome
Female
Frameshift Mutation
Humans
Phenotype
Prognosis
SKP Cullin F-Box Protein Ligases
Exome Sequencing

Chemicals

FBXO28 protein, human
SKP Cullin F-Box Protein Ligases

Word Cloud

Created with Highcharts 10.0.01q41-q42FBXO28mutationsyndromeWDR26frameshiftdeletionphenotypedenovofeaturesgenedeletionsneurodevelopmentaldevelopmentaldelayDDintellectualdisabilityIDepilepsypatientsoverlapdescribedMDSnovelintractablereportedchildcomplexChromosomerecentlyassociatedrecognizableearlychildhoodOMIM612530Withingrouppredominantdistinctdysmorphologybrainanomaliesmagneticresonanceimaging/computedtomographyemergedPreviousreportsledidentificationevolvingsmallestregionincludedseveralpotentiallycausalgenesincludingDISP1TP53BP2recentreportcohortmutationssharedmanyclinicaloriginallymicrodeletiondescribegermline3-year-oldgirlfamilialwhole-exomesequencingstudyidentifiedc972_973delACinsGpArg325GlufsX3probandresultingprematurenonsensegenomicdatabaselargeharborcasejoinspreviouslypatientalsoaffectedfindingssupportideamonogenicdiseasecontributesdysmorphicepilepsy:secondmaycontribute1q41q42F-Boxprotein28SCFchromosomedominantnegativeseizures

Similar Articles

Cited By